ALMED Share Price

Open 5.09 Change Price %
High 5.20 1 Day 0.05 0.98
Low 5.00 1 Week 0.19 3.84
Close 5.14 1 Month -0.34 -6.20
Volume 40002 1 Year -1.75 -25.40
52 Week High 7.03
52 Week Low 4.33
ALMED Important Levels
Resistance 2 5.33
Resistance 1 5.25
Pivot 5.11
Support 1 5.03
Support 2 4.95
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
CS 23.50 3.21%
CS 23.50 3.21%
More..
EPA France Top Gainers Stocks
ALDV 0.13 62.50%
MLNEO 2.83 20.43%
ALSER 168.90 16.32%
APAM 33.78 15.72%
APAM 33.78 15.72%
MLLOI 3.80 15.15%
DEXB 17.47 13.89%
DEXB 17.47 13.89%
ALFBA 0.75 13.64%
MT 4.53 12.97%
More..
EPA France Top Losers Stocks
ALALO 0.03 -25.00%
ALADO 0.04 -20.00%
MLLEM 0.59 -18.06%
EEM 3.15 -12.50%
ALFRE 1.08 -10.00%
MLZAM 1.25 -8.09%
GRVO 19.40 -7.62%
MALT 344.00 -5.23%
ALMAS 0.76 -5.00%
MED 0.40 -4.76%
More..

Medicrea International SA (EPA: ALMED)

ALMED Technical Analysis 3
As on 6th Dec 2016 ALMED Share Price closed @ 5.14 and we RECOMMEND Sell for LONG-TERM with Stoploss of 5.43 & Sell for SHORT-TERM with Stoploss of 5.43 we also expect STOCK to react on Following IMPORTANT LEVELS.
ALMED Target for December
1st Target up-side 5.23
2nd Target up-side 5.57
3rd Target up-side 5.9
1st Target down-side 4.29
2nd Target down-side 3.95
3rd Target down-side 3.62
ALMED Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.medicrea.com
ALMED Address
ALMED
14 Porte du Grand
Neyron
Lyon, 01 700
France
Phone: 33 4 72 01 87 87
Fax: 33 4 72 01 87 88
ALMED Latest News
Interactive Technical Analysis Chart Medicrea International SA ( ALMED EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Medicrea International SA
ALMED Business Profile
Medicrea International Société Anonyme designs, develops, manufactures, and distributes surgical implants and instrumentation for spinal surgery primarily in France, the United States, and the United Kingdom. The company offers a range of implants for the cervical spine, including GRANVIA C, a MRI compatible ceramic cervical disc; C-JAWS, an anterior cervical spinal fixation system; IMPIX C, a sterile PEEK Optima cervical inter body device; Impix C+, a sterile PEEK Optima cervical inter body device that is prefilled with bone substitutes; IMPIX C+ on holder, a sterile PEEK Optima cervical inter body device, which is prefilled with bone substitutes, as well as preassembled on disposable holder; IMPIX Manta+ on holder, a sterile PEEK Optima cervical inter body device, which is preassembled on holder and delivered with disposable instrumentation kit; and LaminoJAWS, a cervical laminoplasty implant with a posterior approach. It also provides implants for the thoracic and lumbar spine comprising PASS LP, a polyaxial spine system; PASS ANT, a polyaxial low profile thoraco-lumbar system for anterior approach; X-JAWS, a lateral lumbar spinal fixation system; L-JAWS, an anterior lumbar spinal fixation system; IMPIX TLIF, a sterile PEEK Optima lumbar inter body device for transforaminal approach; IMPIX ALIF, a sterile PEEK Optima lumbar inter body device for anterior approach; IMPIX LR, a sterile PEEK Optima lumbar ramp shaped inter body device for posterior approach; and OSMOSYS, a synthetic biphasic substitute. The company’s implants are designed to treat scoliosis, degenerative deformation, trauma, and tumors; and are used in various traditional and advanced surgical techniques, such as minimally-invasive surgery. Medicrea International Société Anonyme was founded in 1990 and is headquartered in Lyon, France.